1. Home
  2. ASIC vs SPTX Comparison

ASIC vs SPTX Comparison

Compare ASIC & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ategrity Specialty Insurance Company Holdings

ASIC

Ategrity Specialty Insurance Company Holdings

SELL

Current Price

$24.36

Market Cap

1.3B

Sector

Finance

ML Signal

SELL

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

SELL

Current Price

$19.35

Market Cap

1.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ASIC
SPTX
Founded
2018
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2025
2026

Fundamental Metrics

Financial Performance
Metric
ASIC
SPTX
Price
$24.36
$19.35
Analyst Decision
Buy
Strong Buy
Analyst Count
5
9
Target Price
$28.40
★ $37.13
AVG Volume (30 Days)
73.7K
★ 249.2K
Earning Date
10-21-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 23.44
N/A
EPS
★ 1.47
N/A
Revenue
★ $424,339,000.00
N/A
Revenue This Year
$24.89
N/A
Revenue Next Year
$22.34
N/A
P/E Ratio
$16.69
★ N/A
Revenue Growth
★ 23.41
N/A
52 Week Low
$16.73
$15.79
52 Week High
$29.00
$28.38

Technical Indicators

Market Signals
Indicator
ASIC
SPTX
Relative Strength Index (RSI) 45.26 43.36
Support Level $23.36 $18.79
Resistance Level $25.62 $22.57
Average True Range (ATR) 0.84 1.47
MACD 0.08 -0.09
Stochastic Oscillator 62.35 13.67

Price Performance

Historical Comparison
ASIC
SPTX

About ASIC Ategrity Specialty Insurance Company Holdings

Ategrity Specialty Insurance Co Holdings is a specialty property and casualty insurance holding company focused on the excess and surplus market for small to medium-sized businesses (SMBs) across the United States. Operating through its subsidiaries, the company underwrites small and medium-sized commercial risks across selected industry verticals, including Retail, Real Estate, Hospitality, and Construction. Its operating model uses a technology-driven method to standardize, simplify, and, where appropriate, automate these transactions. The group distributes its products through licensed surplus lines brokers and wholesale agents.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: